Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
9
×
life sciences
national blog main
san francisco blog main
9
×
boston blog main
boston top stories
new york blog main
new york top stories
san francisco top stories
fda
national
national top stories
raleigh-durham blog main
raleigh-durham top stories
boulder/denver blog main
boulder/denver top stories
cancer immunotherapy
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
san diego blog main
san diego top stories
seattle blog main
seattle top stories
springworks therapeutics
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
biotech ipos
cancer
cancer drugs
eli lilly
glaxosmithkline
What
biotech
9
×
companies
days
drug
ipo
research
roundup
week
annual
attention
bio
cancer
hasn’t
ipos
leading
life
medicines
new
news
satsuma
science
slowed
springworks
street
wall
welcomed
abbvie
according
activity
ahead
akcea
alliance
alzheimer’s
ambien
american
arrival
asco
assessed
attendees
august
Language
unset
Current search:
biotech
×
" san francisco blog main "
×
" clinical trials "
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Biotech Roundup: Vaping Toll Rises, NASH News, Akcea Shakeup & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More